FiercePharma13d
Fierce Pharma Asia—Roche, Innovent's ADC deal; Lessons from AZ's China probes; Viatris' warning letter
In separate DLL3 antibody-drug conjugate (ADC) deals, Roche licensed from Innovent Biologics and Ideaya reached for Hengrui.
Hosted on MSN1mon
Viatris launches local ARV production in South Africa: a game changer for HIV treatment accessibility
Viatris invested R100-million in upgrading the Isando facility to align its new manufacturing capability with the global standards and address the government’s goal of increased local ...